Oncostatin M Contributes to Airway Epithelial Cell Dysfunction in Chronic Rhinosinusitis with Nasal Polyps

Int J Mol Sci. 2023 Mar 23;24(7):6094. doi: 10.3390/ijms24076094.

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a typical type-2 inflammation involving several cytokines and is associated with epithelial cell dysfunction. Oncostatin M (OSM) (belonging to the interleukin(IL)-6 family) could be a key driver of epithelial barrier dysfunction. Therefore, we investigated the presence of OSM and IL-6 and the expression pattern of tight junctions (TJs) in the nasal tissue of CRSwNP patients and controls using reverse transcriptase quantitative polymerase chain reaction (RT-qPCR) and Western blotting. Then, their potential role in the epithelial barrier was evaluated in vitro in 27 different primary cultures of human nasal epithelial cells (HNECs) by measuring TJ expression and transepithelial electric resistance (TEER) with or without OSM or IL-6 (1, 10, and 100 ng/mL). The effect on ciliary beating efficiency was evaluated by high-speed videomicroscopy and on repair mechanisms with a wound healing model with or without OSM. OSM and IL-6 were both overexpressed, and TJ (ZO-1 and occludin) expression was decreased in the nasal polyps compared to the control mucosa. OSM (100 ng/mL) but not IL-6 induced a significant decrease in TJ expression, TEER, and ciliary beating efficiency in HNECs. After 24 h, the wound repair rate was significantly higher in OSM-stimulated HNECs at 100 ng/mL. These results suggest that OSM could become a new target for monoclonal antibodies.

Keywords: CRSwNP; IL-6; OSM; ciliary beating efficiency; epithelial electric resistance; nasal epithelium; primary culture; repair rate; tight junctions.

MeSH terms

  • Cells, Cultured
  • Chronic Disease
  • Epithelial Cells / metabolism
  • Humans
  • Nasal Mucosa / metabolism
  • Nasal Polyps*
  • Oncostatin M / metabolism
  • Oncostatin M / pharmacology
  • Rhinitis*
  • Sinusitis* / metabolism
  • Tight Junctions / metabolism

Substances

  • Oncostatin M
  • OSM protein, human

Grants and funding

This research received no external funding.